undamentalytics Newsletter

Mesa Laboratories Inc cash flow statement

In fiscal 2026, Mesa Laboratories Inc's operations generated $42.8m of cash; it spent $3.3m on capital projects, leaving free cash flow of $39.6m. It returned $3.5m in dividends.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Mesa Laboratories Inc: cash flow statement, annual
Fiscal year2011Mar 20112012Mar 20122013Mar 20132014Mar 20142015Mar 20152016Mar 20162017Mar 20172018Mar 20182019Mar 20192020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Cash from operations912111211171726312737392844474356
Depreciation and amortisation223467999131825344555
Stock-based pay00111112469111312131816
Capital spending———————3112453433
Free cash flow———————23292535352342434053
Free cash flow after stock pay———————21252026231130292237
Dividends paid12222222233333344
Share buybacks0100—————————————
Shares issued————————08514600————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: MLAB vs SDGRMLAB vs MRVICTKB vs MLABFLGT vs MLAB

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Mesa Laboratories Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mesa Laboratories Inc.